Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (Ministry of Science and ICT) (No. 2018R1C1B5086011). Funding did not affect the content of the study.
References
- Neogi T. Gout. N Engl J Med 2011;364:443-452. doi: 10.1056/NEJMcp1001124
- Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010;6:30-38. doi: 10.1038/nrrheum.2009.236
- Wortmann RL, Macdonald PA, Hunt B, Jackson RL. Effect of prophylaxis on gout flares after the initiation of urate-lowering therapy: analysis of data from three phase III trials. Clin Ther 2010;32:2386-2397. doi: 10.1016/j.clinthera.2011.01.008
- Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther 2010;12:206. doi: 10.1186/ar2952
- Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832. doi: 10.1016/j.cell.2010.01.040
- Moreno M, Giralt E. Three valuable peptides from bee and wasp venoms for therapeutic and biotechnological use: melittin, apamin and mastoparan. Toxins (Basel) 2015;7:1126-1150. doi: 10.3390/toxins7041126
- Conrad VJ, Hazan LL, Latorre AJ, Jakubowska A, Kim CMH. Efficacy and safety of honey bee venom (Apis mellifera) dermal injections to treat osteoarthritis knee pain and physical disability: a randomized controlled trial. J Altern Complement Med 2019;25:845-855. doi: 10.1089/acm.2019.0121
- Liu XD, Zhang JL, Zheng HG, Liu FY, Chen Y. [Clinical randomized study of bee-sting therapy for rheumatoid arthritis]. Zhen Ci Yan Jiu 2008;33:197-200. Chinese.
- Nam KW, Je KH, Lee JH, Han HJ, Lee HJ, Kang SK, et al. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res 2003;26:383-388. doi: 10.1007/BF02976695
- Karimi A, Ahmadi F, Parivar K, Nabiuni M, Haghighi S, Imani S, et al. Effect of honey bee venom on lewis rats with experimental allergic encephalomyelitis, a model for multiple sclerosis. Iran J Pharm Res 2012;11:671-678.
- Orlowsky EW, Stabler TV, Montell E, Verges J, Kraus VB. Monosodium urate crystal induced macrophage inflammation is attenuated by chondroitin sulphate: pre-clinical model for gout prophylaxis? BMC Musculoskelet Disord 2014;15:318. doi: 10.1186/1471-2474-15-318
- Mitroulis I, Kambas K, Ritis K. Neutrophils, IL-1β, and gout: is there a link? Semin Immunopathol 2013;35:501-512. doi: 10.1007/s00281-013-0361-0
- Harre U, Derer A, Schorn C, Schett G, Herrmann M. T cells as key players for bone destruction in gouty arthritis? Arthritis Res Ther 2011;13:135. doi: 10.1186/ar3508
- Cavalcanti NG, Marques CD, Lins e Lins TU, Pereira MC, Rego MJ, Duarte AL, et al. Cytokine profile in gout: inflammation driven by IL-6 and IL-18? Immunol Invest 2016;45:383-395. doi: 10.3109/08820139.2016.1153651
- Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31:986-1000. doi: 10.1161/ATVBAHA.110.207449
- Robinson DR, Tashjian AH Jr, Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis. J Clin Invest 1975;56:1181-1188. doi: 10.1172/JCI108195
- Aktan F. iNOS-mediated nitric oxide production and its regulation. Life Sci 2004;75:639-653. doi: 10.1016/j.lfs.2003.10.042
- Zamudio-Cuevas Y, Hernandez-Diaz C, Pineda C, Reginato AM, Cerna-Cortes JF, Ventura-Rios L, et al. Molecular basis of oxidative stress in gouty arthropathy. Clin Rheumatol 2015;34:1667-1672. doi: 10.1007/s10067-015-2933-y
- Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001;81:807-869. doi: 10.1152/physrev.2001.81.2.807
- Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. J Biol Chem 2004;279:1323-1329. doi: 10.1074/jbc.M307521200
- Choi MS, Lee SH, Cho HS, Kim Y, Yun YP, Jung HY, et al. Inhibitory effect of obovatol on nitric oxide production and activation of NF-kappaB/MAP kinases in lipopolysaccharide-treated RAW 264.7cells. Eur J Pharmacol 2007;556:181-189. doi: 10.1016/j.ejphar.2006.10.054